Cholesterol News

The American Academy of Neurology held its 2009 annual meeting from April 25 to May 2 in Seattle.

Irma Sotelo-New, a scientist at Isis, worked near a condensing unit in the lab. - Isis Pharmaceuticals is a two-decade-old biotech company in Carlsbad that is on the verge of profitability.

The following is excerpted from a July 1, 2009 Article One Partners press release: Article One Partners, LLC has discovered new prior art impacting the validity of AstraZeneca's Crestor U.S. drug patent, in closing out another round of Patent Studies.

Updated June 13, 2006 Lipid Profile A blood test, or the results of a blood test, that measures levels of lipids, or fats, including cholesterol and triglycerides .

July 1, 2009 -- Millions of people without established heart disease could benefit from cholesterol -lowering statin therapy even if they don't have high cholesterol , a new analysis suggests.

In an article in Science, Noam Zelcer from the LACDR describes a previously unknown mechanism for regulating the amount of LDL cholesterol.

Treatment with a cholesterol-lowering drug might protect against Alzheimer's disease, new research suggests.

You can't look anywhere these days without hearing about fats: They're in your butter, your crackers, your bloodstream and maybe even bulging a little bit over your belt.

Statins cut the risk of heart attacks by 30 per cent even in healthy people, researchers say.

NEW YORK Merkley + Partners has joined Abbott Laboratories' roster of agencies with responsibility for creative duties on three anti-cholesterol drugs, sources said.

The percentage of patients who lowered their elevated low-density lipoprotein "bad" cholesterol to within target levels has nearly doubled in the last decade, according to a recent survey.

Since participating in a clinical trial of red yeast rice, a supplement taken in China for centuries, Jones has gotten his cholesterol under control.

After years of rising cholesterol levels from fatty diets and pudgy waistlines, there's finally good news, experts say.

Washington, June 23 : A new study has shown that popular cholesterol lowering drugs can protect nerve cells against damage, which is known to occur in the brain of Alzheimer's disease patients.

The percentage of patients lowering their elevated "bad" cholesterol to within target levels nearly doubled in the last decade, according to a multi-national survey reported in Circulation: Journal of the American Heart Association .

People in the United States and around the world who are trying to lower their "bad" cholesterol have been succeeding more often in the past decade, new research suggests.

Coronary artery disease is a condition that occurs when the arteries carrying blood to the heart become narrowed or blocked entirely by deposits of plaque, a thick, yellowish, waxy substance.

June 17, 2009 -- By some estimates, as many as 10% of people who take cholesterol-lowering statins experience troubling muscle pain , and many stop taking the drugs because of it.

Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock, getting access to a promising drug candidate pipeline and new markets.

The Phase III data were presented today by Kowa, at the XV International Symposium on Atherosclerosis in Boston .